• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Humoral Immune Responses in Dialysis Patients After mRNA Omicron JN.1 Vaccination.

作者信息

Stankov Metodi V, Hoffmann Markus, Happle Christine, Lürken Karsten, Kempf Amy, Nehlmeier Inga, Stölting Andrea, Pöhlmann Stefan, Dopfer-Jablonka Alexandra, Behrens Georg M N

机构信息

Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.

Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany.

出版信息

Kidney Med. 2025 Jul 7;7(9):101067. doi: 10.1016/j.xkme.2025.101067. eCollection 2025 Sep.

DOI:10.1016/j.xkme.2025.101067
PMID:40918950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12408387/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de69/12408387/63db4507f906/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de69/12408387/63db4507f906/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de69/12408387/63db4507f906/gr1.jpg

相似文献

1
Humoral Immune Responses in Dialysis Patients After mRNA Omicron JN.1 Vaccination.mRNA奥密克戎JN.1疫苗接种后透析患者的体液免疫反应
Kidney Med. 2025 Jul 7;7(9):101067. doi: 10.1016/j.xkme.2025.101067. eCollection 2025 Sep.
2
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients.血液透析患者接受三剂 BNT162b2 和第四剂全剂量 mRNA-1273 疫苗后的纵向细胞和体液免疫应答。
Front Immunol. 2022 Oct 6;13:1004045. doi: 10.3389/fimmu.2022.1004045. eCollection 2022.
3
Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy Individuals.免疫抑制个体和健康个体接种单价奥密克戎JN.1适应性mRNA新冠疫苗后的中和抗体及T细胞针对刺突蛋白的反应
J Med Virol. 2025 Jun;97(6):e70463. doi: 10.1002/jmv.70463.
4
An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant.一种编码严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎XBB.1.5受体结合结构域的信使核糖核酸（mRNA）疫苗可保护小鼠免受JN.1变体的感染。
EBioMedicine. 2025 Jun 6;117:105794. doi: 10.1016/j.ebiom.2025.105794.
5
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients.肝移植受者接种XBB.1.5加强针后对SARS-CoV-2 XBB.1.5和JN.1变体的免疫反应
Viruses. 2024 Dec 19;16(12):1942. doi: 10.3390/v16121942.
6
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years old.一项2/3期试验，旨在研究单价奥密克戎JN.1适配的BNT162b2新冠疫苗在18岁及以上成年人中的安全性和免疫原性。
Vaccine. 2025 Apr 11;52:126869. doi: 10.1016/j.vaccine.2025.126869. Epub 2025 Feb 24.
7
Longitudinal Innate and Heterologous Adaptive Immune Responses to SARS-CoV-2 JN.1 in Transplant Recipients With Prior Omicron Infection: Limited Neutralization but Robust CD4 T-Cell Activity.既往感染奥密克戎的移植受者对SARS-CoV-2 JN.1的纵向固有免疫和异源适应性免疫反应：中和作用有限但CD4 T细胞活性强劲
Transpl Infect Dis. 2025 Jul 2;27(4):e70067. doi: 10.1111/tid.70067.
8
Comparative study of humoral and cellular immunity against SARS-CoV-2 induced by different COVID-19 vaccine types: Insights into protection against wildtype, Delta and JN.1 omicron strains.不同类型新冠疫苗诱导的针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的体液免疫和细胞免疫的比较研究：对预防野生型、德尔塔和JN.1奥密克戎毒株的见解
Vaccine. 2025 Jun 20;59:127270. doi: 10.1016/j.vaccine.2025.127270. Epub 2025 May 22.
9
A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants.一种源自JN.1刺突蛋白的很有前景的mRNA疫苗可针对多种已出现的奥密克戎变体提供保护性免疫。
Mol Biomed. 2025 Mar 4;6(1):13. doi: 10.1186/s43556-025-00258-7.
10
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections.多次接种新冠疫苗以及反复感染奥密克戎非 JN.1 或 JN.1 毒株后的奥密克戎亚变体中和作用及抗原图谱分析
Sci Rep. 2025 Jan 9;15(1):1454. doi: 10.1038/s41598-024-84138-0.

本文引用的文献

1
Effectiveness of 2023-2024 COVID-19 vaccines against COVID-19-associated hospitalizations among adults aged ≥18 years with end stage kidney disease - United States, September 2023-April 2024.2023 - 2024年新冠疫苗对≥18岁终末期肾病成年人新冠相关住院治疗的有效性 - 美国，2023年9月 - 2024年4月
Vaccine. 2025 May 10;55:127010. doi: 10.1016/j.vaccine.2025.127010. Epub 2025 Apr 3.
2
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）从XBB到JN.1抗原性转变的抗体反应演变
Nature. 2025 Jan;637(8047):921-929. doi: 10.1038/s41586-024-08315-x. Epub 2024 Nov 7.
3
Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination.
新型冠状病毒奥密克戎 JN.1 变异株 mRNA 疫苗接种后的体液免疫
Lancet Infect Dis. 2024 Nov;24(11):e674-e676. doi: 10.1016/S1473-3099(24)00603-0. Epub 2024 Sep 25.
4
Omicron variant infection worsen the prognosis of haemodialysis (HD) patients.奥密克戎变异株感染使血液透析（HD）患者的预后恶化。
Ann Med. 2024 Dec;56(1):2394582. doi: 10.1080/07853890.2024.2394582. Epub 2024 Aug 25.
5
Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany.德国血液透析患者接种BNT162b2 XBB.1.5疫苗后的免疫反应。
Lancet Infect Dis. 2024 Mar;24(3):e145-e146. doi: 10.1016/S1473-3099(23)00783-1. Epub 2024 Jan 8.
6
Vaccine Effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 in CKD.BNT162b2 和 CoronaVac 疫苗对慢性肾脏病患者中 SARS-CoV-2 奥密克戎 BA.2 的有效性。
Clin J Am Soc Nephrol. 2024 Apr 1;19(4):418-428. doi: 10.2215/CJN.0000000000000376. Epub 2023 Dec 26.
7
Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study.SARS-CoV-2 mRNA疫苗接种后透析和移植患者抗体显著下降的风险：来自观察性Dia-Vacc研究的六个月数据。
Lancet Reg Health Eur. 2022 Apr 11;17:100371. doi: 10.1016/j.lanepe.2022.100371. eCollection 2022 Jun.
8
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment.COVID-19 与透析：临床影响、免疫反应、预防和治疗。
Kidney Int. 2022 May;101(5):883-894. doi: 10.1016/j.kint.2022.01.022. Epub 2022 Feb 14.
9
A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon.一种基于水疱性口炎病毒复制子的生物测定法，用于快速灵敏地测定多种 I 型干扰素。
PLoS One. 2011;6(10):e25858. doi: 10.1371/journal.pone.0025858. Epub 2011 Oct 5.